KDA Group Inc. (CVE:KDA) Insider Sells C$53,850.00 in Stock

KDA Group Inc. (CVE:KDA) insider Tenshi Life Sciences Pte. Limited sold 179,500 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of C$0.30, for a total value of C$53,850.00.

Tenshi Life Sciences Pte. Limited also recently made the following trade(s):

• On Friday, October 11th, Tenshi Life Sciences Pte. Limited sold 3,000 shares of KDA Group stock. The stock was sold at an average price of C$0.30, for a total value of C$900.00.
• On Monday, October 7th, Tenshi Life Sciences Pte. Limited sold 74,000 shares of KDA Group stock. The stock was sold at an average price of C$0.30, for a total value of C$22,200.00.
• On Friday, October 4th, Tenshi Life Sciences Pte. Limited sold 48,500 shares of KDA Group stock. The stock was sold at an average price of C$0.30, for a total value of C$14,550.00.
• On Monday, September 30th, Tenshi Life Sciences Pte. Limited sold 153,500 shares of KDA Group stock. The stock was sold at an average price of C$0.30, for a total value of C$46,050.00.
• On Wednesday, September 25th, Tenshi Life Sciences Pte. Limited sold 77,000 shares of KDA Group stock. The stock was sold at an average price of C$0.30, for a total value of C$23,100.00.
• On Monday, September 23rd, Tenshi Life Sciences Pte. Limited sold 43,500 shares of KDA Group stock. The stock was sold at an average price of C$0.30, for a total value of C$13,050.00.

KDA Group Stock Performance

KDA Group stock opened at C$0.29 on Friday. The company has a quick ratio of 0.35, a current ratio of 2.10 and a debt-to-equity ratio of 7.36. The company has a market capitalization of C$50.87 million, a P/E ratio of -7.50 and a beta of 1.24. The stock’s 50 day moving average is C$0.25 and its 200 day moving average is C$0.27. KDA Group Inc. has a twelve month low of C$0.14 and a twelve month high of C$0.66.

About KDA Group

KDA Group Inc, together with its subsidiaries, provides solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates through three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. It provides pharmacy staff replacement services, professional and continued medical training services, pharmacy re-engineering services, and pharmaceutical training services.